Skip to main content
SIR 2026 Event Main banner
Philips_IVUS_Left_Banner
MediView_Experience_Left Banner
Merit Medical_Embosphere_Left Banner

SIR 2026

Scientific Session

Nonvascular Interventions

General IR

Session: General IR 3

Fluoroscopy-Guided Percutaneous Transthoracic Pleural Forceps Biopsy in Patients with Exudative Pleural Effusion

Tuesday, April 14, 2026
4:12 PM - 4:21 PM ET
Location: 716A

    Presenting Author(s)

  • IN

    Inchul Nam, MD (he/him/his)

    Associate professor
    Jeju National University Hospital, Cheju-do, Republic of Korea

    • Author/Co-author(s)

  • JW

    Jungho Won, MD

    Associate Professor
    Gyeongsang National University Hospital, Kyongsang-namdo, Republic of Korea

  • DR

    Doo Ri, MD

    Assistant Professor
    Jeju National University Hospital, Cheju-do, Republic of Korea

Purpose: This study aimed to evaluate the diagnostic performance and procedural characteristics of fluoroscopy-guided percutaneous transthoracic pleural forceps biopsy (PTPFB) in patients with exudative pleural effusion.

Materials and Methods: Patients with exudative pleural effusion who underwent PTPFB between May 1, 2014, and February 28, 2023, were included in this retrospective study. The interval between percutaneous catheter drainage (PCD) and PTPFB, number of biopsies, procedural time, and procedure-related complications were evaluated. The sensitivity, specificity, and accuracy of diagnosing malignancy were computed for pleural cytology using PCD drainage, PTPFB, and combined PTPFB and pleural cytology.

Results: Seventy-one patients, comprising 50 male and 21 female (mean age, 69.5 ± 15.3 years), were included in this study. The final diagnoses were benign lesions in 48 patients (67.6%) and malignant in 23 patients (32.4%). The overall interval between PCD and biopsy was 2.4 ± 3.7 days. The interval between PCD and biopsy in the group that underwent delayed PTPFB was 5.2 ± 3.9 days. The mean number of biopsies was 4.5 ± 1.3. The mean procedural time was 4.4 ± 2.1 minutes. Minor bleeding complications were reported in one patient (1.4%). The sensitivity, specificity, and accuracy for pleural cytology, PTPFB, and combined PTPFB and pleural cytology were 47.8% (11/23), 100% (48/48), and 83.1% (59/71), respectively; 65.2% (15/23), 100% (48/48), and 88.7% (63/71), respectively; and 78.3% (18/23), 100% (48/48), and 93.0% (66/71), respectively. The sensitivity and accuracy of cytology combined with PTPFB were significantly higher than those of cytological testing alone (P = 0.008 and 0.001, respectively).

Conclusion: Fluoroscopy-guided PTPFB is an accurate and safe diagnostic technique for patients with exudative pleural effusion, with acceptable diagnostic performance, low complication rates, and reasonable procedural times.